Page last updated: 2024-08-23

mifepristone and Psoriasis

mifepristone has been researched along with Psoriasis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brito, PS; Cabrini, DA; Facundo, VA; Favero, GM; Horinouchi, CD; Mendes, DA; Nolte, S; Otuki, MF; Santos, AR; Soley, BD	1

Other Studies

1 other study(ies) available for mifepristone and Psoriasis

Article	Year
Anti-proliferative and anti-inflammatory effects of 3β,6β,16β-Trihydroxylup-20(29)-ene on cutaneous inflammation. Journal of ethnopharmacology, 2017, Jan-04, Volume: 195 Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cell Line; Cell Proliferation; Chronic Disease; Dermatitis, Contact; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Female; Hormone Antagonists; Humans; Keratinocytes; Mice; Mifepristone; Proliferating Cell Nuclear Antigen; Psoriasis; Receptors, Glucocorticoid; Skin; Tetradecanoylphorbol Acetate; Time Factors; Triterpenes	2017

Article

Year

Anti-proliferative and anti-inflammatory effects of 3β,6β,16β-Trihydroxylup-20(29)-ene on cutaneous inflammation.

Journal of ethnopharmacology, 2017, Jan-04, Volume: 195

Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cell Line; Cell Proliferation; Chronic Disease; Dermatitis, Contact; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Female; Hormone Antagonists; Humans; Keratinocytes; Mice; Mifepristone; Proliferating Cell Nuclear Antigen; Psoriasis; Receptors, Glucocorticoid; Skin; Tetradecanoylphorbol Acetate; Time Factors; Triterpenes

2017